Clinical Trial 469

Winter Park, FL 32789


Study Summary:

Study evaluating the efficacy and safety of study drug for treatment of Crohn's Disease. Length of study is 6 weeks. There is an extension study lasting 1 year.


Qualified Participants Must:

• Must have failed treatment with Remicade (infliximab) due to allergic reaction or lack of efficacy.


Qualified Participants May Receive:

None


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.